Clinical Research

Clinical Research studies open to Capital Cardiology Associates patients

Clinical Research at Capital Cardiology Associates

Meet the team

Meet the Clinical Research team at Capital Cardiology Associates.

Dr Robert Benton

Dr. Robert Benton received his Bachelor of Arts degree from Johns Hopkins University and his Medical Degree from The University of Vermont College of Medicine. As the Director of the Capital Cardiology Associates, PC, Division of Clinical Research, Dr. Benton has participated in approximately 30 clinical trials in both the inpatient and outpatient settings. Many of these have been landmark studies published in the such journals at the New England Journal of Medicine, The Journal of the American Medical Association, Circulation and The Lancet.
Read more on Dr. Robert Benton

Dr. Parag Shah attended Guy’s Hospital in London, UK where he received his medical degree in 1987. In 1995, he completed a Fellowship in Cardiology at Albany Medical Center in Albany, NY. Dr. Shah is Board Certified in Cardiology.
Read Dr. Shah’s full bio here

Dr Parag Shah

Amanda O’Malley BSN, RN, CCRC is the CCA Clinical Research Division Manager.

Erin Orvis, LPN, CCRC is a Licensed Practical Nurse who graduated from SUNY Canton in 2010. She will graduate in May 2017 with her A.A.S. in Nursing and will soon be taking the State Board Exam soon to become a Registered Nurse. Erin earned the title of Certified Clinical Research Coordinator from The Association of Clinical Research Professionals which further demonstrates her passion and dedication to the research field. She has been an employee with CCA for 4 years now. Erin is from the Thousand Islands and moved to the Capital Region in 2010.

Thomas Spadola, LPN graduated from the Capital Region Boces LPN program in 2009. He has held various nursing jobs since 2009 and has been with Capital Cardiology Associates for one year. He is a lifelong resident of the Capital Region and is married with two children.

Current Clinical Research Studies

Capital Cardiology Associates is participating in the following clinical research studies

Explanation of current research studies and directions on how to participate

Click on the box to read more on the study and enrollment availability.

Augustus

An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention

-Acute Coronary Syndrome OR Percutaneous Coronary Intervention within 14 days of enrollment
-Atrial Fibrillation or Atrial Flutter
-Planned use of P2Y12 Inhibitor for 6 months

Read more on this study

Now accepting patients!

Camellia

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment with BELVIQ (lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk Factors

-BMI ≥ 27 and Patients with previous Cardiovascular Disease

Read more on this study

Not accepting patients.

Partners 3

To establish the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement(AVR)

-Transcatheter Aortic Valve Replacement (TAVR) -VS- Surgical Aortic Valve Replacement (SAVR)
-10 year study

*In conjunction with Albany Medical Center

Read more on this study

Now accepting patients!

Portico

The Portico transcatheter aortic valve provides a minimally invasive treatment for patients diagnosed with severe aortic stenosis, an abnormal narrowing of the aortic valve. It is used in patients who may be at a high or extreme risk for open heart surgery

– Not a good candidate for surgical valve replacement
– Patient will either receive portico valve or commercially available valve

*In conjunction with Albany Medical Center

Read more on this study

Now accepting patients!

Strength

Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh 
Cardiovascular Risk PatienTs with Hypertriglyceridemia

Triglycerides 180-500, LDL <100, HDL<45 and Patients with previous Cardiovascular Disease Read more on this study

Not accepting patients.

Amaze

This study is being conducted to determine whether the LARIAT procedure can help patients with persistent and/or longstanding persistent Afib when done in addition to catheter ablation.
Patients in the study will be divided into two groups. Each group will receive one of the following treatments:
1. Closing the left atrial appendage with the LARIAT procedure, followed by catheter ablation
2. Catheter ablation only
*In conjunction with Albany Medical Center

Read more on this study

Now accepting patients!

Emperor 1

A phase III, randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10mg compared to placebo, in patient with Chronic Heart Failure with preserved Ejection Fraction

-Chronic Heart Failure
-Ejection Fraction >40%
-Prior Heart Failure medications should be stable

Read more on this study

Now accepting patients!

Emperor 2

A phase III, randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10mg compared to placebo, in patient with Chronic Heart Failure with reduced Ejection Fraction

-Chronic Heart Failure
-Ejection Fraction <40% -Prior Heart Failure medications should be stable Read more on this study

Now accepting patients!

Reveal

A large-scale, randomized placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease.

Read more on this study

Not accepting patients.

Stroke AF

A study to compare the incidence of atrial fibrillation (AF) through 12 months between continuous cardiac rhythm monitoring with the Reveal LINQ TM Insertable Cardiac Monitor (ICM) (continuous monitoring arm) and standard of care (SoC) medical treatment (control arm) in subjects with a recent ischemic stroke of presumed known origin

-Ischemic Stroke within the past 10 days

*In conjunction with Albany Medical Center

Read more on this study

Now accepting patients!

Questions?

Contact Us